JP2017520364A5 - - Google Patents

Download PDF

Info

Publication number
JP2017520364A5
JP2017520364A5 JP2017519960A JP2017519960A JP2017520364A5 JP 2017520364 A5 JP2017520364 A5 JP 2017520364A5 JP 2017519960 A JP2017519960 A JP 2017519960A JP 2017519960 A JP2017519960 A JP 2017519960A JP 2017520364 A5 JP2017520364 A5 JP 2017520364A5
Authority
JP
Japan
Prior art keywords
carbon dioxide
fluticasone
vol
equipment according
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017519960A
Other languages
English (en)
Japanese (ja)
Other versions
JP6785227B2 (ja
JP2017520364A (ja
Filing date
Publication date
Priority claimed from US14/315,132 external-priority patent/US11554229B2/en
Application filed filed Critical
Priority claimed from PCT/EP2015/064463 external-priority patent/WO2015197798A1/en
Publication of JP2017520364A publication Critical patent/JP2017520364A/ja
Publication of JP2017520364A5 publication Critical patent/JP2017520364A5/ja
Application granted granted Critical
Publication of JP6785227B2 publication Critical patent/JP6785227B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017519960A 2014-06-25 2015-06-25 経鼻投与 Active JP6785227B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/315,132 US11554229B2 (en) 2013-03-26 2014-06-25 Nasal administration
US14/315,132 2014-06-25
PCT/EP2015/064463 WO2015197798A1 (en) 2014-06-25 2015-06-25 Nasal administration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020115917A Division JP7090124B2 (ja) 2014-06-25 2020-07-03 経鼻投与

Publications (3)

Publication Number Publication Date
JP2017520364A JP2017520364A (ja) 2017-07-27
JP2017520364A5 true JP2017520364A5 (https=) 2018-08-16
JP6785227B2 JP6785227B2 (ja) 2020-11-18

Family

ID=53489954

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017519960A Active JP6785227B2 (ja) 2014-06-25 2015-06-25 経鼻投与
JP2020115917A Active JP7090124B2 (ja) 2014-06-25 2020-07-03 経鼻投与

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020115917A Active JP7090124B2 (ja) 2014-06-25 2020-07-03 経鼻投与

Country Status (14)

Country Link
EP (2) EP3160556A1 (https=)
JP (2) JP6785227B2 (https=)
KR (1) KR102458964B1 (https=)
CN (1) CN106470724A (https=)
AU (3) AU2015279154A1 (https=)
BR (1) BR112016029926A2 (https=)
CA (1) CA2953207A1 (https=)
ES (1) ES3034743T3 (https=)
IL (1) IL249585B (https=)
MX (1) MX390453B (https=)
RU (1) RU2016152090A (https=)
SG (1) SG11201610685XA (https=)
WO (1) WO2015197798A1 (https=)
ZA (1) ZA201608785B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201713899D0 (en) * 2017-08-30 2017-10-11 Indosys Ltd Multi-dose medicament delivery device
US11744967B2 (en) * 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN108421138A (zh) * 2017-12-25 2018-08-21 宫本海 一种鼻腔雾化吸药器
WO2019222463A1 (en) * 2018-05-16 2019-11-21 Massachusetts Institute Of Technology Methods and apparatus for passive, proportional, valveless gas sampling and delivery
EP4051107A4 (en) 2019-10-28 2023-11-01 The Research Foundation for The State University of New York DEVICES, SYSTEMS AND METHODS FOR MONITORING ARTERIAL CARBON DIOXIDE

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416884D0 (en) * 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
GB0121568D0 (en) * 2001-09-06 2001-10-24 Optinose As Nasal delivery device
CN1736502A (zh) 1999-03-03 2006-02-22 奥普蒂诺斯公司 鼻传送装置
JP4932109B2 (ja) * 1999-07-12 2012-05-16 キャプニア インコーポレイテッド 頭痛、鼻炎及び他のありふれた病気を治す方法及び装置
US20070039615A1 (en) * 1999-11-08 2007-02-22 Capnia, Incorporated Methods and apparatus for treating rhinitis
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
EP1259282A4 (en) 2000-02-28 2007-05-23 Capnia Inc METHOD AND DEVICE FOR THE TRANSCUTANEOUS INFUSION OF CARBON DIOXIDE FOR LOCAL PAIN TREATMENT AND THE TREATMENT OF OTHERS
ZA200306564B (en) * 2001-02-26 2004-10-15 Optinose As Nasal devices.
GB2403154B (en) * 2002-04-04 2007-01-24 Optinose As Nasal devices
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
GB0320171D0 (en) * 2003-08-28 2003-10-01 Optinose As Delivery devices
EP1658105B1 (en) * 2003-08-29 2018-03-14 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
MX2007001561A (es) * 2004-08-04 2007-04-16 Schering Corp Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas.
GB0503738D0 (en) * 2005-02-23 2005-03-30 Optinose As Powder delivery devices
GB0602980D0 (en) * 2006-02-14 2006-03-29 Optinose As Delivery device and method
GB0604319D0 (en) * 2006-03-03 2006-04-12 Optinose As Nasal delivery
GB2440316A (en) * 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
US8337817B2 (en) * 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
GB2448193A (en) * 2007-04-05 2008-10-08 Optinose As Nasal delivery device
GB0719299D0 (en) * 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
WO2009095684A1 (en) * 2008-02-01 2009-08-06 Vectura Limited Pulmonary formulations of triptans
US20100196483A1 (en) * 2009-02-04 2010-08-05 Activaero Gmbh Research & Development Method for treatmentof severe and uncontrollable asthma
DE102011103347B4 (de) * 2011-05-27 2014-10-30 Meda Pharma Gmbh & Co. Kg Nasale pharmazeutische Formulierung
MX2014009898A (es) * 2012-02-16 2015-07-06 Capnia Inc Dispensador de gas con boquilla de difusion.
ES2920802T3 (es) * 2013-03-26 2022-08-09 Optinose As Administración nasal

Similar Documents

Publication Publication Date Title
RU2015145449A (ru) Интраназальное введение
JP2017520364A5 (https=)
JP5185109B2 (ja) スプレー用ゲルタイプ皮膚・粘膜付着型製剤およびそれを用いた投与システム
ZA202007717B (en) Nicotine formulation
JP2019089775A (ja) 高濃度の一酸化窒素の投与法
JP2014530637A5 (https=)
WO2008036801A3 (en) Methods and systems of delivering medication via inhalation
JP2008044951A5 (https=)
CN106163598A (zh) 尼古丁粉末吸入器
ATE451920T1 (de) Pulverinhaliermittel mit sumatriptan und herstellungsverfahren dafür
MX2011012043A (es) Sistema farmaceutico para suministro transmembrana.
CN102421474A (zh) 气雾药物输送装置与方法
RU2016152090A (ru) Интраназальное введение
JP2014513091A5 (https=)
BR112021013244A8 (pt) Dispositivo de entrega de fármaco nasal
IL318427A (en) Varenicline compound for use as a medication for treating dry eye, increasing tear production and treating eye discomfort and a pramipexole preparation containing varenicline
MXPA04011020A (es) Metodos, dispositivos y formulaciones para terapia endobronquial dirigida.
JP2022535920A5 (https=)
CN205924634U (zh) 麻醉呼吸回路结构
JP2019516797A5 (https=)
NZ744942A (en) Compositions and methods for treating nasal and paranasal mucosa diseases with nicotinic acetylcholine receptor agonists
JP2020073510A5 (https=)
WO2015038092A3 (en) Carbon dioxide and saline nasal delivery methods and delivery devices
AU2012221841A1 (en) Method and arrangement for generating a gas stream comprising nitric oxide
CN104436386B (zh) 辅助呼吸气雾气体的装置及调节呼吸气雾气体的方法